We report on a smart application of carbon nanotubes for kinetic stabilization of lipid particles that contain self-assembled nanostructures in their cores. The preparation of lipid particles requires rather low concentrations of carbon nanotubes permitting their use in biomedical applications such as drug delivery.
Introduction:
Over the last few decades, nanotechnology has emerged as a powerful tool especially in the field of preclinical development of medicine to combat notorious diseases such as cancer 1 . In this context, nanoscale structures with size <1000 nm are extensively explored as delivery vehicle of various active biomolecules such as drugs, proteins, nucleic acids, genes and diagnostic imaging agents [1] [2] [3] [4] . These biomolecules are either encapsulated within the nanoparticles or conjugated onto the surface of nanoparticles and are released at the site of action by triggers such as pH or temperature 5, 6 . Although extremely small in size, the large surface area of these nanoparticles proves to be greatly advantageous for targeted delivery of active biomolecules. The control over the particle size and biocompatibility is of utmost importance in order to optimize the therapeutic efficacy and hence the applicability of nanoparticles 7, 8 . Lipids [9] [10] [11] [12] [13] , polymers 14, 15 , metals 16, 17 and carbon nanotubes 18, 19 have been commonly employed as nanocarriers for various biomedical and pharmaceutical applications.
Moreover, nanocarrier applications based on lipid self-assembled nanostructures have a wide significance in many other disciplines including food and cosmetic industries 20, 21 . For instance, they are used in protein crystallization 22 , separation of biomolecules 23 , as food stabilizers e.g. in desserts 24 , and in the delivery of active molecules such as nutrients, flavours and perfumes [25] [26] [27] [28] [29] [30] [31] . Self-assembled lipid nanostructures not only have the ability to release bioactive molecules in a controlled and targeted fashion [32] [33] [34] [35] [36] [37] [38] but they are also able to protect the functional molecules from chemical and enzymatic degradation 39, 40 . Although planar fluid bilayer is the most common nanostructure formed by amphiphilic lipid molecules in presence of water, other structures such as hexagonal and cubic are also commonly observed 20, 41, 42 . The type of nanostructure formed depend upon the lipids' molecular shape structure, the lipid composition in water as well as on the physico-chemical conditions employed such as temperature and pressure 43 . The applicability of non-planar lipid nanostructures especially that of cubic phases, is restricted because of their high viscosity and non-homogeneous domain consistency. These problems are overcome by dispersing the lipid nanostructures in large amount of water to form oil-in-water (O/W) emulsions containing micron or submicron sized lipid particles. In this manner, a suitable product of low viscosity can be prepared while retaining the original lipid self-assembled structure inside the dispersed particles. The formation of these internally self-assembled particles (abbreviated as ISAsomes 44 e.g. cubosomes from cubic phases and hexosomes from hexagonal phases) commonly requires a combination of an high energy input step and the addition of stabilizers such as surfactants or polymers. Recent research in this direction demonstrates the application of various solid particles 45 including silica nanoparticles 46 , clay [47] [48] [49] and carbon nanotubes 50 for the stabilization of aforementioned emulsions, suitably termed as Pickering 51 or Ramsden-Pickering emulsions 52 .
In recent years, carbon based nanostructures such as single-walled carbon nanotubes (SWCNTs), multi-walled carbon nanotubes (MWCNTs) and fullerenes have received a great deal of attention as novel biomaterials 53, 54 . The main concerns are their toxicity [55] [56] [57] [58] , water insolubility 59 and hence their biocompatibility 56 . An efficient way to tackle these issues is the surface functionalization using non-toxic and biocompatible molecules such as lipids. In presence of water, lipids interact with CNTs in a manner that hydrophobic surface of CNTs is shielded from polar aqueous medium whereas the lipid hydrophilic head groups aid their solubility or dispersion in water 60, 61 . Lipids are integral constituents of cellular organelles as well as some food materials, therefore their decoration should ideally decrease the in vivo toxicity of CNTs. Biomedical applications based independently on CNTs 18, 19 and lipid nanostructures [9] [10] [11] [12] [13] are under extensive development but the applications that combine properties of the two are not yet well-explored.
In this work, we employ two different types of lipids and three types of CNTs of which SWCNTs are in the pristine form whereas MWCNTs are functionalized with hydroxyl and carboxylic groups. We have used very low concentrations of CNTs to prepare the dispersions whose stability depends upon several factors e.g. the type of lipid, type of CNT, ratio of lipid to CNT used, as well as on the sonication parameters employed such as power and duration. This video protocol provides technical details of a method of kinetically stabilizing lipid nanoparticles using various CNT-stabilizers.
Protocol:
Caution: CNTs used in this work are in the nanoparticulate form which may have additional hazards compared to their bulk counterparts. Inhalation of graphite, both natural and synthetic, can cause pneumoconiosis 62 similar to coal worker's pneumoconiosis. Moreover, there have been concerns relating to the toxicity of carbon based nanostructures and some of the previous studies suggest acute and chronic toxicity associated with the inhalation of CNTs [63] [64] [65] [66] [67] [68] . Hence, avoid inhalation of the fine CNT powder and handle it with great care. If inhaled, move to fresh air. If breathing is difficult, use pure oxygen instead and seek medical consultation. Solution/dispersion formulations of CNTs are rather safe to handle.
Caution: Lipids and surfactants used in this study are food-grade materials and thus nonhazardous in general, but they are irritant to eyes and skin, and also highly flammable. Hence, please use all appropriate safety practices such as use of engineering controls (fume hood) and personal protective equipment (safety glasses, gloves, lab coat, full length pants, closed-toe shoes) when handling or preparing nanoparticle samples. In case of contact with skin or eyes, immediately flush skin or eyes with plenty of water for at least 15 min. Seek medical advice if required.
Preparation of lipid/water bulk phases
Caution: Store the lipids in the refrigerator at 4°C. Pure grade lipids should be stored in the freezer (-20°C). Aliquot them into small glass vials to avoid contamination of the whole stock and convenience of handling. Other chemicals including CNTs and surfactants can be stored at room temperature but keep them away from direct sunlight.
1.1
Keep lipids, i.e. Dimodan U (DU) and Phytantriol (PT) at room temperature for 15-20 min prior to opening the bottle/vial lid in order to avoid moisture condensation. (Note: DU is a distilled glyceride comprising 96% monoglycerides and the rest are diglycerides and free fatty acids. Two major monoglyceride components in DU are linoleate (62%) and oleate (25%). Hence the hydrophobic part of DU mainly contains C18 chains (91%), the exact composition of which is as follows; C18:2 (61.9%), C18:1 (24.9%), and C18:0 (4.2%), where C18 indicates 18C-chain and the number after colon indicates number of C=C bonds. PT is a mixture of 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol optical isomers. It does not contain an ester functional group but consists of highly branched phytanyl tail with a tri-hydroxy headgroup. Both of DU and PT form cubic phases in presence of excess water which is also the case for the cores of stabilized lipid particles 13, 45 ).
1.2
Melt the lipids by putting vials in a hot water bath or a beaker containing water maintained above 60°C (heating magnetic stirrer: 230 V, 50 Hz, 630 W or similar to be used to heat the water in a beaker).
1.2. Alternatively heat vials using block heaters. Do not heat the lipid containing vials directly on the hot plate in order to avoid temperature gradient and subsequent lipid decomposition.
1.3
Weigh 500 mg of the molten lipid, in previously weighed microcentrifuge tube (with conical snap cap, 1.5 mL), using a Pasteur glass pipette with a latex bulb.
1.4
A L M microcentrifuge tube.
1.5
Mix the components manually for 15 min using tiny (custom-built) spatula. Make such a spatula by flattening the sharp end of a syringe needle (0.9 mm x 40 mm cannula length) using a plier.
1.6
Centrifuge the lipid/water mixture for 10 min at a speed of 2000 x g. Again stir the mixture manually for 10 min, then equilibrate it for 24 hrs. Before characterizing the samples, stir them for 5 min and then leave them at room temperature.
1.7
To ensure the formation of an equilibrium lipid phase throughout the entire tube, perform about 10 freeze-thaw cycles and intermittently carry out a centrifugation step as defined above. Both the DU and PT form highly viscous bulk lipid phases making it difficult to handle them manually (Figure 1) . 
Note: The above protocol (section 1) is only necessary, if one would like to compare nanostructural behaviour (lattice type and dimensions of self-assembly) of dispersed particles with the bulk lipid phase and/or use it as a control to confirm the retention of original nanostructure.

2.
Preparation of surfactant stabilized lipid particles 2.1 Prepare a 0.2% (w/w) surfactant (pluronic F127) solution in water.
2.1.1 Dissolve 200 mg of the surfactant (white fluffy powder) in 100 mL ultrapure water by stirring it for 20-30 min (on a magnetic plate using a magnetic stirrer bar). Pluronic F127 is a non-ionic surfactant and is commonly used as emulsion stabilizer. It is a triblock copolymer of PEO 99 -PPO 67 -PEO 99 , and hence takes long time to dissolve in water.
2.2
Add 500 mg of molten DU or PT (using a Pasteur glass pipette) to a glass vial (scintillation soda-lime fitted with foil lined urea cap, 20 mL).
2.3
Add 9.5 g of the 0.2% F127 solution.
2.4
On the probe ultrasonication machine, tightly clamp the vial to the retort stand jaw (Retort Stand Set with stand, clamp, base, rod, rubber 3 jaw and bosshead), so that it can withstand the vibrations generated by sonication.
2.5
Insert the solid titanium alloy probe (13 mm diameter x 139 mm length) attached to the Cell Sonicator. Adjust the height and position of the vial to ensure that its sides and bottom are not touching to the probe. A distance of 0.5 cm between the probe tip and the bottom of the glass vial gives good results.
2.6
Sonicate the mixture for 10 min in a pulsed mode with 1 sec pulse mediated by 1 sec delay time at 35% (of the maximum) power. The vial becomes very hot due to the heat generated during sonication. Therefore, allow it to cool down to room temperature before taking it off the clamp.
2.7
Store the milky-formed dispersion at room temperature for at least 24 h, prior to further use. This is to ensure its stability against phase separation.
Note: Before and after using the probe, clean it with acetone, dry with a paper towel, then rinse it with ultrapure water and dry it once more.
3.
Preparation of dispersions of pure CNTs in water 3.1 In two separate beakers, weigh in 4 mg powdered MWCNT-OH and MWCNT-COOH, both of which are black in color.
3.2
Add 500 mL ultrapure water to each beaker. Using a probe ultrasonicator sonicate the mixtures for 2 min in a continuous pulse mode at 40% (of the maximum) power. The resulting concentration of the MWCNT dispersion is 8 µg/mL (stock solution).
3.3
Dilute the MWCNT stock solution with appropriate amounts of ultrapure water to achieve 6.25, 5, 4, 2 µg/mL MWCNT dispersions.
3.4
Sonicate these dispersions as described before (see 3.2).
3.5
Similarly, disperse 3 mg of powdered SWCNT (also black in color) in 500 mL ultrapure water to make a 6 µg/mL SWCNT dispersion (stock solution).
3.6
Dilute the SWCNT stock solution and sonicate them as described above (see 3.2) to obtain 0.5, 0.4, 0.3125, 0.2 µg/mL SWCNT dispersions. 
4
Preparation of CNT-stabilized nanostructured lipid particles (Figure 1) 4.1 Weigh in 500 mg of the molten DU into a glass vial.
4.2 Add 9.5 mL of the 6 µg/mL SWCNT dispersion to the vial.
4.3
Sonicate the CNT-DU mixture using the same parameters as used for making pure CNT dispersions (see 3.2). Upon cooling to room temperature, the CNT-stabilized lipid particles with conserved internally self-assembled nanostructure will be ready.
4.4
In a similar way, prepare the lipid particles using the 0.4 µg/mL and 0.2 µg/mL SWCNT dispersions.
4.5
Follow the protocols 4.1 to 4.4 to make lipid particles using MWCNT-OH and MWCNT-COOH but using different concentrations, namely 8, 4 and 2 µg/mL of CNT.
4.6
Similarly, prepare three different CNT-PT dispersions using 4 µg/mL MWCNT-OH and MWCNT-COOH as well as 0.4 µg/mL SWCNT. Note that the CNT-PT dispersions require less power (35% of the maximum) but longer time (15 min) in a continuous pulse mode. Cool the dispersions to room temperature and leave them for 24 h before characterizing them.
Note: Sonication parameters may differ for different lipids (as for DU and PT here) and for different compositions; they need to be optimized to achieve well-stabilized dispersions.
5
Monitoring the stability of the CNT-stabilized lipid dispersions
5.1
Monitor the stability of the dispersions by visual observation: check if the dispersions are destabilized or if lumps have formed in the dispersions.
5.2
Take photos (with digital camera) at regular intervals. For instance, take pictures of dispersions every day in the first week, then every other day for a week followed by once a week for the next two weeks, and finally once a month as per requirement.
Representative Results:
The following results represent a) the stability of dispersions, b) the size distribution of lipid particles, c) the type of self-assembly and d) the evidence for lipid coating of the CNTs. The stability of dispersions ( Figure 2 ) was monitored using a 5 MP camera with auto-focus and LED flash. where the CNT to lipid ratio was optimum; below and above stable emulsion did not form because of a too little or too great amount of CNTs, respectively. An arrow indicates a typical CNT lump in an unstable emulsion. These measurements were performed for a range of DU-CNT dispersions; representative ones are shown here (figure reproduced from reference [50] with permission from The Royal Society of Chemistry).
Small angle X-ray scattering (SAXS) patterns were recorded in order to determine the lattice type of the inner nanostructure of the stabilized isasomes (Figure 3a) . The SAXSpace camera is connected to an analytical X-ray generating equipment (ISO-DEBYEFLEX3003) with a sealed-tube Cu-anode operating at 40 kV and 50 mA. The X-ray tube is chilled with a closed water circuit. The SAXSpace collimation block unit transforms the divergent polychromatic X-ray beam into a vertically focused line shaped beam of Cu-K radiation with a wavelength, F SAXS permits to detect a minimum scattering vector, q min , of 0.04 nm -1 (q is the scattering angle). A semi-transparent beam stop enables to record the attenuated primary beam profile for the exact determination of the zero scattering vector and transmission correction. Each of the studied samples is enclosed in the same vacuum-tight, reusable 1 mm quartz capillary to guarantee exactly the same scattering volume. The capillary was placed in the temperature controlled sample stage equipped with Peltier elements, which is connected to a water cooling thermostat to get rid of the excess heat. All experiments were performed at 25°C with a temperature stability of 0.1°C. A vacuum pump was used to evacuate the sample chamber achieving a minimum pressure of~1 mbar. The 1D scattering patterns were recorded with a micro-strip X-ray detector. This detector is single photon counting and has a sensitive area of 64×8 mm 2 comprising 1280 channels each with a channel size of 0.05 × 8 mm (v × h). The sample-detector distance was 317.09 mm. Each sample was exposed three times for 300 sec, and their integrated scattering profiles were averaged.
The SAXStreat software was employed to correct the scattering patterns with respect to the position of the primary beam. The SAXS data was further transmission-corrected by setting the attenuated scattering intensity at q = 0 to unity and the background was subtracted using the SAXSQuant software. The scattering vector q was calibrated with silver-behenate, which has a known lattice spacing of 5.84 nm 69 . All recorded diffraction patterns could be indexed with the space group Pn3m (diamond bicontinuous cubic phase), in which the 110, 111, 200, 211, 220 and 221 reflections were identified (Figure 3a) . The lattice parameter, a, for Pn3m phase was determined by linear regression applying the following lattice equation
(1) where h, k and l are the Miller indices. The size and size distribution of dispersed lipid particles ( Figure 3b ) were determined using a laser particle size analyer. The interactions between the CNTs and lipid particles were studied using Raman spectroscopy (Figure 4 ). The samples: CNTs, lipid and CNT-stabilized lipid particles were dehydrated, first using nitrogen gas and then by keeping them in a vacuum desiccator for about 20 minutes. The spectra were recorded using a Horiba Jobin-Yvon LabRAM HR800 spectrometer equipped with an Andor electromagnet charged coupled device (CCD) for light detection and a video camera to guide spectral collection. A 532 nm excitation line of Nd:YAG laser was utilized to collect spectra in the range 100-4000 cm using a grating of 600 g.mm blazed at 750 nm. 50x long working distance objective with a numerical Before the measurements, the instrument was calibrated to the 520.8 cm spectral line of silicon. All spectra were collected at room temperature (25°C) by placing the sample on Calcium Fluoride slides. Spectra were acquired using the 532 nm laser and accumulated 5 times with 1% exposure for 10 sec. LabSpec 6 spectroscopy software suite used for preprocessing the raw data and immediate data interrogation. 
Discussion: Stabilization of lipid particles
Three different CNTs are used to stabilize the lipid dispersions; two of which are multiwalled and functionalized using -OH and -COOH groups, and one is single walled and nonfunctionalized (pristine). The CNTs varied in size as follows (diameter x length): MWCNT-COOH -9.5 nmx1.5 µm; MWCNT-OH -8-15 nm x 50 µm; SWCNT -1-2 nm x 1-3 µm. The powdered CNTs were dispersed in water by probe ultra-sonication. Aforementioned sizes of CNTs are likely to decrease further due to ultra-sonication, albeit unevenly. CNT dispersions in pure water started separating after about 20 min, hence further work was executed within this time i.e. addition of lipids and second sonication. The latter (ultrasonication performed on the lipid-CNT mixtures) assists in melting and breaking down large and inconsistent lipid domains formed during the hydration into sub-micron portions. Dispersing the bulk lipid in this manner facilitates the equilibrium formation of self-assembled nanostructures, which otherwise requires rigorous freeze-thaw cycles and/or long time (days to weeks). The bulk lipid phase breaks into nanoparticles whereas the lipid coated CNTs supposedly form shells around them. Ultra-sonication enhances the hydrophobic interactions between the CNTs and the alkyl chains of lipid molecules thereby decorating CNTs by lipid alkyl chains. Thus coated CNTs stabilize the fragmented lipid phase leading to a particulate emulsion. This mutual stabilization avoids the aggregation of CNTs as well as disperses the lipid particles. Such dispersions are also called Pickering (due to the use of solid particles) type oil-in-water (O/W) emulsions, where the lipids form an 'oil phase' while 'excess water' constitutes the continuous emulsion medium (Figure 1 ). Ultrasonication parameters (pulse length, delay time and power), physicochemical parameters of a stabilizer (e.g. dimensions, functionalization), concentration of dispersed phase and composition of the dispersion (e.g. CNT to lipid ratio) are crucial to guarantee the final stability of the dispersions and therefore need to be optimized for different (lipid) systems.
Optimization of CNT to lipid ratio for stable emulsions
A wide range of concentrations for each CNT-type (Figure 2 ) was employed to stabilize the self-assembled nanostructures obtained from two different lipids. However, homogeneous and stable emulsions are only formed in a particular range of CNT to lipid ratio; too high ratios cause aggregation of CNTs, while too low ratios lead to unstable emulsions, because there are not enough CNTs to accomplish a sufficient particle-surface coverage. Best
Morphological characterization of lipid particles
The SAXS measurements verify that lipid particles of PT retain the original cubic phase nanostructure (shown by bulk phase) (Figure 3a) . We presume that the cubic phase is also retained in case of DU particles, however this needs further confirmation as it was not studied in the current work. The lattice parameter observed for bulk Pn3m phase of PT is 6.84 nm, which upon dispersion increases to 7.1 nm. The lower lattice parameter for bulk phase is attributed to the lack of excess water, which can be also confirmed by the coexistence of Ia3d phase (peaks marked by * in Figure 3a) . The Ia3d phase is usually found under limited water conditions. The lattice parameters for Pn3m phase observed for all dispersed lipid particles (i.e. stabilized by surfactant as well as by all CNT types) are practically the same indicating excess water conditions. This also rules out the possibility of CNT-driven disturbances at the molecular level which, otherwise, could have triggered a change of the lipid phase.
The size distributions of the cubosomes are given by the volume-weighted distributions as shown in Figure 3b . Although the CNT-stabilized particles display a wide size distribution, majority of the particles exhibit sizes between 532-760 nm which are comparable to the size of surfactant stabilized lipid particles (674 nm).
Lipid coating of CNTs
For pure CNTs, typical Raman graphite bands are seen in the Raman spectra. The G band which corresponds to the in-plane vibration of 'C-C bond', the D band (not shown) which is G overtone of the D band 70 are clearly observed. Upon interaction of CNT with lipid and on formation of CNT-stabilized lipid particles (compare green and blue curves in Figure 4 ), a shift to higher wavenumbers (blue shift) is observed. The observed blue shift, could be due to: i) high pressure exerted on CNTs during ultrasonication resulting in their dispersion as opposed to a bundled state when pure 70, 71 , and/or ii) interactions between CNTs and lipid molecules via coating of CNTs by lipids (such blue shift has been reported previously by Douroumis et al. 72 for lipid coated SWCNTs).
The decrease in relative intensities of CNT peaks and appearance of lipid signals (from red curves of pure lipid (Figure 4 ) further confirms the coating of CNTs by lipid molecules. This suggests that the hydrophobic interactions between CNTs and alkyl chains of lipid molecules decorate the CNT surface in such a way that hydrophilic head groups face aqueous regions thus stabilizing O/W emulsion, as shown by the schematic in Figure 4d .
We have demonstrated a smart and simple method of kinetically stabilizing the O/W type emulsion of nanostructured lipid particles using various CNTs. Very low concentrations (<10 µg/mL) of CNTs are adequate to stabilize the lipid nanoparticle dispersion, which is promising specifically for in vivo applications. Decoration of CNTs by lipid molecules is anticipated to minimize their toxicity while improving the biocompatibility. The prospect of loading functional molecules within the lipid self-assembly as well as on the CNT surface provide limitless potential to the CNT-stabilized lipid particles in the area of biomedical sciences especially in the context of combination therapies against major diseases 73 .
